Mark Harnett
- Urology top 5%
- Urinary Bladder and Prostate Research 3
- Rheumatology top 10%
- Anesthesiology and Pain Medicine top 10%
- Anesthesia and Sedative Agents 4
- Parasitology top 10%
- Small Animals top 10%
- Veterinary Pharmacology and Anesthesia 6
-
- Anesthesia and Pain Management 4
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 4
-
- Opioid Use Disorder Treatment 3
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
-
- Gastrointestinal motility and disorders 2
- Co-authors
- David StaskinScott A. ReinesLuAnn SabounjianBobby W. SandageChristina WangAdrian S. DobsRonald S. SwerdloffNicholas Silver
- Journals
- Blood (4 papers)The Journal of Clinical Pharmacology (2 papers)Alzheimer s & Dementia Translational Research & Clinical Interventions (2 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Mark Harnett
26 papers receiving 515 citations
Peers
Comparison fields: 5 of 85
- Urology 117
- Rheumatology 108
- Anesthesiology and Pain Medicine 37
- Parasitology 43
- Small Animals 38
Countries citing papers authored by Mark Harnett
This map shows the geographic impact of Mark Harnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Harnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Harnett more than expected).
Fields of papers citing papers by Mark Harnett
This network shows the impact of papers produced by Mark Harnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Harnett. The network helps show where Mark Harnett may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Harnett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 0 | |
| 3 | 2021 | 85 | |
| 4 | 2021 | 10 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 2 | |
| 7 | 2020 | 5 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 3 | |
| 10 | 2020 | 12 | |
| 11 | 2020 | 31 | |
| 12 | 2019 | 19 | |
| 13 | 2019 | 8 | |
| 14 | 2013 | 27 | |
| 15 | 2012 | 3 | |
| 16 | 2010 | 51 | |
| 17 | 2009 | 11 | |
| 18 | 2006 | 15 | |
| 19 | 2005 | 54 | |
| 20 | 2004 | 44 |
About Mark Harnett
Mark Harnett is a scholar working on Small Animals, Anesthesiology and Pain Medicine, Gastroenterology, Urology and Pharmaceutical Science, having authored 27 papers that have together received 545 indexed citations. Recurring topics across this work include Veterinary Pharmacology and Anesthesia (6 papers), Anesthesia and Pain Management (4 papers), Anesthesia and Sedative Agents (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Opioid Use Disorder Treatment (3 papers), Urinary Bladder and Prostate Research (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Gastrointestinal motility and disorders (2 papers). The work is most often cited by research in Urology (117 citations), Rheumatology (108 citations), Anesthesiology and Pain Medicine (37 citations), Parasitology (43 citations) and Small Animals (38 citations). Mark Harnett has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include David Staskin, Scott A. Reines, LuAnn Sabounjian, Bobby W. Sandage, Christina Wang, Adrian S. Dobs, Ronald S. Swerdloff, Nicholas Silver, David E. Elliott and S. B. Hanauer. Their work appears in journals such as Blood, The Journal of Clinical Pharmacology, Alzheimer s & Dementia Translational Research & Clinical Interventions, Nature Medicine and Molecular Genetics and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.